Who invested in Gmax Biopharm?
Gmax Biopharm's investors include Cowin Capital.
Who invested in Gmax Biopharm
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$78Mraised across 1 round since 2021, from 1 source
- Latest round
- Series C, $78MMar 2021
- Investors
- 1
The rounds
- Mar 2021
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Gmax Biopharm
How much has Gmax Biopharm raised?
Gmax Biopharm has raised $78M across 1 round since 2021.
When did Gmax Biopharm last raise?
Gmax Biopharm's most recent round was a Series C of $78M in Mar 2021.
What was Gmax Biopharm's biggest round?
Its most recent round, $78M in Mar 2021, is also its largest on record.
Who backed Gmax Biopharm first?
Gmax Biopharm's first round on record, in Mar 2021, was backed by Cowin Capital.
What stage is Gmax Biopharm at?
Gmax Biopharm's latest named round is a Series C, in Mar 2021.
Companies like Gmax Biopharm
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.